1. Home
  2. BUUU vs SGMO Comparison

BUUU vs SGMO Comparison

Compare BUUU & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUUU

BUUU Group Limited Class A Ordinary Share

N/A

Current Price

$7.98

Market Cap

133.4M

ML Signal

N/A

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.51

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUUU
SGMO
Founded
2017
1995
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.4M
155.1M
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
BUUU
SGMO
Price
$7.98
$0.51
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$4.71
AVG Volume (30 Days)
44.6K
9.3M
Earning Date
12-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$6,328,425.00
$32,875,000.00
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
N/A
P/E Ratio
$150.87
N/A
Revenue Growth
8.88
N/A
52 Week Low
$3.67
$0.38
52 Week High
$9.50
$2.84

Technical Indicators

Market Signals
Indicator
BUUU
SGMO
Relative Strength Index (RSI) N/A 51.55
Support Level N/A $0.42
Resistance Level N/A $0.55
Average True Range (ATR) 0.00 0.05
MACD 0.00 0.02
Stochastic Oscillator 0.00 67.23

Price Performance

Historical Comparison
BUUU
SGMO

About BUUU BUUU Group Limited Class A Ordinary Share

BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: